Ola Blomqvist

1.4k total citations
18 papers, 1.2k citations indexed

About

Ola Blomqvist is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology. According to data from OpenAlex, Ola Blomqvist has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Ola Blomqvist's work include Neurotransmitter Receptor Influence on Behavior (13 papers), Receptor Mechanisms and Signaling (8 papers) and Nicotinic Acetylcholine Receptors Study (8 papers). Ola Blomqvist is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (13 papers), Receptor Mechanisms and Signaling (8 papers) and Nicotinic Acetylcholine Receptors Study (8 papers). Ola Blomqvist collaborates with scholars based in Sweden, United States and France. Ola Blomqvist's co-authors include Jörgen A. Engel, Mia Ericson, Bo Söderpalm, Bo Söderpalm, Daniel Johnson, Hans Nissbrandt, Peter Olausson, Henry R. Kranzler, Carlos A. Hernández–Ávila and Jeffrey Van Kirk and has published in prestigious journals such as The British Journal of Psychiatry, European Journal of Pharmacology and Behavioural Brain Research.

In The Last Decade

Ola Blomqvist

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Blomqvist Sweden 12 944 848 199 169 115 18 1.2k
Elin Löf Sweden 14 648 0.7× 543 0.6× 146 0.7× 127 0.8× 80 0.7× 15 929
Joan Holgate Australia 15 552 0.6× 520 0.6× 191 1.0× 83 0.5× 76 0.7× 20 846
Peter W. Marinelli Canada 15 871 0.9× 502 0.6× 212 1.1× 108 0.6× 164 1.4× 17 1.1k
A. D. Lê Canada 11 728 0.8× 325 0.4× 199 1.0× 62 0.4× 188 1.6× 12 961
William M. Doyon United States 14 801 0.8× 548 0.6× 137 0.7× 42 0.2× 206 1.8× 15 1.0k
Luis A. Natividad United States 17 600 0.6× 429 0.5× 196 1.0× 33 0.2× 145 1.3× 29 916
William A. Corrigall Canada 10 930 1.0× 970 1.1× 227 1.1× 28 0.2× 139 1.2× 10 1.2k
Maureen E.M. Benwell United Kingdom 13 1.1k 1.2× 1.4k 1.7× 337 1.7× 26 0.2× 102 0.9× 14 1.7k
Wanda Dyr Poland 17 811 0.9× 438 0.5× 150 0.8× 74 0.4× 125 1.1× 54 1.0k
Robert J. Fitch United States 6 516 0.5× 315 0.4× 151 0.8× 161 1.0× 111 1.0× 6 877

Countries citing papers authored by Ola Blomqvist

Since Specialization
Citations

This map shows the geographic impact of Ola Blomqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Blomqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Blomqvist more than expected).

Fields of papers citing papers by Ola Blomqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Blomqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Blomqvist. The network helps show where Ola Blomqvist may publish in the future.

Co-authorship network of co-authors of Ola Blomqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Blomqvist. A scholar is included among the top collaborators of Ola Blomqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Blomqvist. Ola Blomqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Young, Allan H., Pierre‐Michel Llorca, Peter Falkai, et al.. (2024). Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial. The British Journal of Psychiatry. 226(2). 72–78.
2.
Blomqvist, Ola, et al.. (2003). Self-Efficacy as a Predictor of Relapse During Treatment for Alcohol Dependence. Addictive Disorders & Their Treatment. 2(4). 135–145. 5 indexed citations
3.
Kranzler, Henry R., Stephen Armeli, Howard Tennen, et al.. (2003). Targeted Naltrexone for Early Problem Drinkers. Journal of Clinical Psychopharmacology. 23(3). 294–304. 76 indexed citations
4.
Kranzler, Henry R., Stephen Armeli, Howard Tennen, et al.. (2003). . Journal of Clinical Psychopharmacology. 23(3). 294–304. 6 indexed citations
5.
Blomqvist, Ola, Carlos A. Hernández–Ávila, Jeffrey Van Kirk, Jed E. Rose, & Henry R. Kranzler. (2002). Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of Alcohol. Alcoholism Clinical and Experimental Research. 26(3). 326–331. 71 indexed citations
6.
Blomqvist, Ola, Carlos A. Hernández–Ávila, Jeffrey Van Kirk, Jed E. Rose, & Henry R. Kranzler. (2002). Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of Alcohol. Alcoholism Clinical and Experimental Research. 26(3). 326–331. 1 indexed citations
7.
Blomqvist, Ola, Joel Gelernter, & Henry R. Kranzler. (2000). Family-Based study of DRD2 alleles in alcohol and drug dependence. American Journal of Medical Genetics. 96(5). 659–664. 37 indexed citations
8.
Söderpalm, Bo, Mia Ericson, Peter Olausson, Ola Blomqvist, & Jörgen A. Engel. (2000). Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behavioural Brain Research. 113(1-2). 85–96. 193 indexed citations
9.
Ericson, Mia, Ola Blomqvist, Jörgen A. Engel, & Bo Söderpalm. (1998). Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. European Journal of Pharmacology. 358(3). 189–196. 164 indexed citations
10.
Blomqvist, Ola, Mia Ericson, Jörgen A. Engel, & Bo Söderpalm. (1997). Accumbal dopamine overflow after ethanol: Localization of the antagonizing effect of mecamylamine. European Journal of Pharmacology. 334(2-3). 149–156. 148 indexed citations
11.
Blomqvist, Ola, Mia Ericson, Daniel Johnson, Jörgen A. Engel, & Bo Söderpalm. (1996). Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. European Journal of Pharmacology. 314(3). 257–267. 213 indexed citations
12.
Blomqvist, Ola. (1996). Ethanol and central nicotinic acetylcholine receptors : a behavioral and neurochemical study in rodents. Gothenburg University Publications Electronic Archive (Gothenburg University). 1 indexed citations
13.
Blomqvist, Ola, et al.. (1995). Characterization of the Anticonflict Effect of MK‐801, a Non‐Competitive NMDA Antagonist. Pharmacology & Toxicology. 76(2). 122–127. 11 indexed citations
14.
Blomqvist, Ola, et al.. (1995). The yohimbine-induced anticonflict effect in the rat, part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms. Journal of Neural Transmission. 100(3). 175–189. 18 indexed citations
15.
Blomqvist, Ola, Bo Söderpalm, & Jörgen A. Engel. (1994). 5-HT1A receptor agonists reduce ethanol-induced locomotor activity in mice. Alcohol. 11(2). 157–161. 23 indexed citations
16.
Johnson, Daniel H., et al.. (1993). SENSITIZATION TO NICOTINE ENHANCES ETHANOL PREFERENCE IN RATS AND ETHANOLINDUCED LOCOMOTOR ACTIVITY IN MICE. Behavioural Pharmacology. 4(4). 461–461. 1 indexed citations
17.
Blomqvist, Ola, Jörgen A. Engel, Hans Nissbrandt, & Bo Söderpalm. (1993). The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. European Journal of Pharmacology. 249(2). 207–213. 168 indexed citations
18.
Blomqvist, Ola, Bo Söderpalm, & Jörgen A. Engel. (1992). Ethanol-induced locomotor activity: involvement of central nicotinic acetylcholine receptors?. Brain Research Bulletin. 29(2). 173–178. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elin Löf Breakdown of academic impact, for papers by Joan Holgate Breakdown of academic impact, for papers by Peter W. Marinelli Breakdown of academic impact, for papers by A. D. Lê Breakdown of academic impact, for papers by William M. Doyon Breakdown of academic impact, for papers by Luis A. Natividad Breakdown of academic impact, for papers by William A. Corrigall Breakdown of academic impact, for papers by Maureen E.M. Benwell Breakdown of academic impact, for papers by Wanda Dyr Breakdown of academic impact, for papers by Robert J. Fitch
Rankless by CCL
2026